These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 946404)

  • 1. The excretion and distribution of inorganic mercury in the rat as influenced by several chelating agents.
    Gabard B
    Arch Toxicol; 1976 Jan; 35(1):15-24. PubMed ID: 946404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of immediate and delayed treatment with 2,3-dimercaptopropane-1-sulphonate on the distribution and toxicity of inorganic mercury in mice and in foetal and adult rats.
    Wannag A; Aaseth J
    Acta Pharmacol Toxicol (Copenh); 1980 Feb; 46(2):81-8. PubMed ID: 7361570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mercuric chloride poisoning with dimercaptosuccinic acid and diuretics: preliminary studies.
    Aaseth J; Alexander J; Raknerud N
    J Toxicol Clin Toxicol; 1982 Apr; 19(2):173-86. PubMed ID: 6180172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research on the detoxifying effects of certain chelating agents after poisoning of the isolated rabbit kidney by mercury salts].
    Truhaut R; Boudènce C; Jouany JM
    Ann Biol Clin (Paris); 1968; 26(10):1267-73. PubMed ID: 4973154
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of mercaptodextran on distribution and toxicity of mercury in mice.
    Aaseth J
    Acta Pharmacol Toxicol (Copenh); 1973; 32(6):430-41. PubMed ID: 4800750
    [No Abstract]   [Full Text] [Related]  

  • 6. Chelation in metal intoxication: effect of thiol chelators on renal cytosolic mercury.
    Tandon SK; Khandelwal S; Behari JR
    Z Gesamte Hyg; 1986 Sep; 32(9):540-1. PubMed ID: 3798979
    [No Abstract]   [Full Text] [Related]  

  • 7. The therapeutic use of 2,3-dimercaptopropane-1-sulfonate in two cases of inorganic mercury poisoning.
    Campbell JR; Clarkson TW; Omar MD
    JAMA; 1986 Dec; 256(22):3127-30. PubMed ID: 3783847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.
    Zalups RK; Bridges CC
    Chem Res Toxicol; 2012 Sep; 25(9):1825-38. PubMed ID: 22667351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meso-dimercaptosuccinic acid a chelating agent for the treatment of mercury and lead poisoning.
    Friedheim E; Crovi C; Wakker CH
    J Pharm Pharmacol; 1976 Sep; 28(9):711-2. PubMed ID: 10397
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on poisonous metals. XX. Effects of chelating agents on distribution and excretion of inorganic mercury in rats].
    Shimada H; Kiyozumi M; Honda T; Kojima S
    Yakugaku Zasshi; 1988 Dec; 108(12):1209-14. PubMed ID: 3251030
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the chelating action of methicillin in prolonged experimental metallic mercury poisoning.
    Twardowska-Saucha K
    Br J Ind Med; 1986 Sep; 43(9):611-4. PubMed ID: 3756112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiments with different antidotes in acute poisoning by different mercury compounds. Effects on survival and on distrinution and excretion of mercury.
    Swensson A; Ulfvarson U
    Int Arch Arbeitsmed; 1967; 24(1):12-50. PubMed ID: 4971273
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 2,3-dimercaptopropanol (BAL) on urinary excretion and brain content of mercury.
    Magos L
    Br J Ind Med; 1968 Apr; 25(2):152-4. PubMed ID: 5647978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
    Garza-Ocañas L; Torres-Alanís O; Piñeyro-López A
    J Toxicol Clin Toxicol; 1997; 35(6):653-5. PubMed ID: 9365436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats.
    Pingree SD; Simmonds PL; Woods JS
    Toxicol Sci; 2001 Jun; 61(2):224-33. PubMed ID: 11353131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meso-dimercaptosuccinic acid, a chelating agent for the treatment of mercury poisoning.
    Friedheim E; Corvi C
    J Pharm Pharmacol; 1975 Aug; 27(8):624-6. PubMed ID: 239185
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of standard chelating agents for acute mercuric chloride poisoning in mice.
    Jones MM; Basinger MA; Weaver AD; Davis CM; Vaughn WK
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):363-72. PubMed ID: 7367752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mercury excretion by poisoning in the mouse: comparative effect of any protective drugs (author's transl)].
    Fialip J; Bastide P; Payard M
    Ann Pharm Fr; 1978; 36(11-12):587-92. PubMed ID: 112907
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effects of chelating agents on distribution, excretion, and renal toxicity of inorganic mercury in rats.
    Kojima S; Shimada H; Kiyozumi M
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):471-84. PubMed ID: 2781144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of occupational poisoning: report of 10 cases.
    Salvi RM
    J Toxicol Clin Exp; 1988; 8(3):205-10. PubMed ID: 3172028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.